From colonic polyps to colon cancer: Pathophysiology, clinical presentation, screening and colonoscopic therapy

Minerva Gastroenterologica e Dietologica

Volumn 53, Issue 4, 2007, Pages 351-373

  Cappell, M S ^a,b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Division of Gastroenterology   (United States)

Author keywords

Adenoma; Chemoprevention; Colonic neoplasms; Colonoscopy; Endoscopy; Endosonography; Genetics; Molecular biology; Screening; Virtual colonoscopy

Indexed keywords

PROTEIN P53;

CANCER STAGING; CHROMOSOME LOSS; CLINICAL FEATURE; COLON CANCER; COLON POLYP; COLON POLYPOSIS; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DNA METHYLATION; ENDOSCOPY; GENE MUTATION; GROUPS BY AGE; HETEROZYGOSITY; HUMAN; MISMATCH REPAIR; REVIEW; SCREENING; SIGMOIDOSCOPY;

ADENOMA; AGED; COLON; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; ENDOSONOGRAPHY; HUMANS; MASS SCREENING; MIDDLE AGED; MUTATION; NEOPLASM STAGING; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38649123979     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. Hassan C, Zullo A, Laghi A, Reitano I, Taggi F, Cerro P et al. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy. Dig Liver Dis 2007;39:242-50.
2. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006;130:1872-85.
3. Levin B, Barthel JS, Burt RW, David DS, Ford JM, Giardiello FM et al. Colorectal Cancer Screening Clinical Practice Guidelines. J Natl Compr Canc Netw 2006;4:384-420.
4. Cappell MS, Goldberg ES. The relationship between the clinical presentation and spread of colon cancer in 315 consecutive patients: a significant trend of earlier cancer detection from 1982 through 1988 at a university hospital. J Clin Gastroenterol 1992;14:227-35.
5. Levine JS, Ahnen DJ. Adenomatous polyps of the colon. N Engl J Med 2006;355:2551-7.
6. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:132-41.
7. Federici A, Giorgi Rossi P, Bartolozzi F, Farchi S, Borgia P, Guasticchi G. Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy. Prev Med 2005;41:30-5.
8. Taylor ML, Anderson R. Colorectal cancer screening: physician attitudes and practices. WMJ 2002;101:39-43.
9. rd. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002;97:3186-94.
10. Tsai CJ, Lu DK. Small colorectal polyps: histopathology and clinical significance. Am J Gastroenterol 1995;90:988-94.
11. Heald RJ, Bussey HJR. Clinical experiences at St. Mark's Hospital with multiple synchronous cancers of the colon and rectum. Dis Colon Rectum 1975;18:6-10.
12. Cappell MS. From colonic polyps to colon cancer: Pathophysiology, clinical presentation, and diagnosis. Clin Lab Med 2005;25:135-77.
13. Bussey HJR. Familial polyposis coli: family studies, histopathology, differential diagnosis and results of treatment. Baltimore: Johns Hopkins University Press; 1975.
14. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology 1987;93:1009-13.
15. Jass JR. Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol 2004;2:1-8.
16. Higuchi T, Jass JR. My approach to serrated polyps of the colorectum. J Clin Pathol 2004;57:682-6.
17. Chulmska A, Boudova L, Zamecnik M. Sessile serrated adenomas of the large bowel: clinicopathologic and immunohistochemical study including comparison with common hyperplastic polyps and adenomas. Cesk Patol 2006;42:133-8.
18. Spring KJ, Zhao ZZ, Karamatic R, Walsh MD, Whitehall VL, Pike T et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 2006;131:1400-7.
19. Veale AMO. Intestinal Polyposis. Eugenis Laboratory Memoirs Series 40. London: Cambridge University Press; 1965.
20. Herrera L, Kataki S, Gibas L, Pietrzak E, Sandberg AA. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986;25:473-6.
21. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJ, Ellis A, Gorman P et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-6.
22. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253:661-5.
23. Robbins DH, Itzkowitz SH. The molecular and genetic basis of colon cancer. Med Clin N Am 2002;86:1467-95.
24. Peltomaki P, Aaltonen LA, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-2.
25. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
26. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-61.
27. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
28. Kolodner RD, Hall NR, Lipford J, Kane MF, Rao MRS, Morrison P et al. Structure of the human MSH2 locus and analysis of the two Muir-Torre kindreds for MSH2 mutations. Genomics 1994;24:516-26.
29. Ivanovich JL, Read TE, Ciske DJ, Kodner IJ, Whelan AJ. A practical approach to familial and hereditary colon cancer. Am J Med 1999;107:68-77.
30. Zigman AF, Lavine JE, Jones MC, Boland CR, Carethers JM. Localization of the Bannayan-Riley-Ruvalcaba syndrome to chromosome 10q23. Gastroenterology 1997;113:1433-7.
31. Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996;13:114-6.
32. Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998;280:1086-8.
33. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998;18:38-43.
34. Suraweera N, Duval A, Reperant M, Vaury C, Furlan D, Leroy K et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 2002;123:1804-11.
35. Jen J, Powell SM, Papadopoulos N, Smith KJ, Hamilton SR, Vogelstein B et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994;54:5523-6.
36. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Igari T, Tanaka K et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 1994;54:3011-20.
37. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
38. Kern SE, Fearon ER, Tersmette KW, Enterline JP, Leppert M, Nakamura Y et al. Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 1989;261:3099-103.
39. Brenner DA. Gastrointestinal basic science 2002-2003: the year in review. Clin Gastroenterol Hepatol 2004;2:9-13.
40. Myohanen SK, Baylin SB, Herman JG. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 1998;58:591-3.
41. Burri N, Shaw P, Bouzourene H, Sordat I, Sordat B, Gillet M et al. Methylation silencing and mutations of the p14ARF and p16lNK4a genes in colon cancer. Lab Invest 2001;81:217-29.
42. Shannon BA, Iacopetta BJ. Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: associations with clinicopathological features. Cancer Lett 2001;167:91-7.
43. Hassan C, Zullo A, Risio M, Rossini FP, Morini S. Histologic risk factors and clinical outcome in colorectal malignant polyp: A pooled-data analysis. Dis Colon Rectum 2005;48:1588-96.
44. Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 2005;48:1161-8.
45. Gryfe R. Clinical implications of our advancing knowledge of colorectal cancer genetics: inherited syndromes, prognosis, prevention, screening and therapeutics. Surg Clin N Am 2006;86:787-817.
46. Church JM. Clinical significance of small colorectal polyps. Dis Colon Rectum 2004;47:481-5.
47. Cappell MS. The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps. Med Clin N Am 2005;89:1-42.
48. Sandhu IS, Bhutani MS. Gastrointestinal endoscopic ultrasonography. Med Clin N Am 2002;86:1289-317.
49. Fisher ER, Sass R, Palekar A, Fisher B, Wolmark N. Dukes' classification revisited: Findings from the national surgical adjuvant breast and bowel projects (protocol R-01). Cancer 1989;64:2354-60.
50. Boland CR. Malignant tumors of the colon. Yamada T, Alpers D, Kaplowitz N, Laine L, Dwyang C, Powell DW editors. Textbook of gastroenterology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 1940-90.
51. Hawk ET, Umar A, Richmond E, Viner JL. Prevention and therapy of colorectal cancer. Med Clin N Am 2005;89:85-110.
52. Howe GR, Benito E, Castelleto R, Cornee J, Esteve J, Gallagher RP et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst 1992;84:1887-96.
53. Tamura K, Ishiguro S, Munakata A, Yoshida Y, Nakaji S, Sugawara K. Annual changes in colorectal carcinoma incidence in Japan: analysis of survey data on incidence in Aomori Prefecture. Cancer 1996;78:1187-94.
54. Satia-Abouta J, Galanko JA, Martin CF, Ammerman A, Sandler RS. Food groups and colon cancer risk in African-Americans and Caucasians. Int J Cancer 2004;109:728-36.
55. Ries LAG, Eisner MP, Kosary CL, Miller BA, Clegg L, Edwards BK. SEER cancer statistics review, 1973-1998. Bethesda, MD: National Cancer Institute; 2001.p. 1-22.
56. Cappell MS, Friedel D. The role of sigmoidoscopy and colonoscopy in the diagnosis and management of lower gastrointestinal disorders: endoscopic findings, therapy, and complications. Med Clin N Am 2002;86:1253-88.
57. Grem JL, Steinberg SM, Chen AP, McAtee N, Cullen E, Hamilton JM et al. The utility of monitoring carcinoembryonic antigen during systemic therapy for advanced colorectal disease. Oncol Rep 1998;5:559-67.
58. Rex DK. Colonoscopy: a review of its yield for cancers and adenomas by indication. Am J Gastroenterol 1995;90:353-65.
59. Lieberman D. Rectal bleeding and diminutive colon polyps. Gastroenterology 2004;126:1167-74.
60. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME, Colorectal Cancer Study Group. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.
61. Simon JB. Fecal occult blood testing: clinical value and limitations. Gastroenterologist 1998;6:66-78.
62. Church TR, Ederer F, Mandel JS. Fecal occult blood screening in the Minnesota Study: Sensitivity of the screening test. J Natl Cancer Inst 1997;89:1440-8.
63. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsene D, Boutreux S et al. Comparison of a guaiac-based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average-risk population. Gut 2007;56:210-4.
64. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
65. Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997;112:17-23.
66. Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy: National Polyp Study Work Group. N Engl J Med 2000;342:1766-72.
67. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology 2003;124:544-60.
68. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
69. McCallion K, Mitchell RM, Wilson RH, Kee F, Watson RG, Collins JS et al. Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut 2001;48:522-5.
70. Anderson JC, Alpern Z, Messina CR, Lane B, Hubbard P, Grimson R et al. Predictors of proximal neoplasia in patients without distal adenomatous pathology. Am J Gastroenterol 2004;99:472-7.
71. Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997;112:24-8.
72. Chiu HM, Chang CY, Chen CC, Lee YC, Wu MS, Lin JT et al. A prospective comparative study of narrow-band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of colorectal neoplasia. Gut 2007;56:373-9.
73. Syngal S, Bandipalliam P, Boland R. Surveillance of patients at high risk for colorectal cancer. Med Clin N Am 2005;89:61-84.
74. Jeevaratnam P, Cottier DS, Browett PJ, Van De Water NS, Pokos V, Jass JR. Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J Pathol 1996;179:20-5.
75. Desai DC, Neale KF, Talbot IC, Hodgson SV, Phillips RK. Juvenile polyposis. Br J Surg 1995;82:14-7.
76. Zerhouni EA, Rutter C, Hamilton SR, Balfe DM, Megibow AJ, Francis IR et al. CT and MR imaging in the staging of colorectal carcinoma: Report of the Radiology Diagnostic Oncology Group II. Radiology 1996;200:443-51.
77. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002;224:748-56.
78. Harewood GC, Wiersema MJ, Nelson H, Maccarty RL, Olson JE, Clain JE et al. A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology 2002;123:24-32.
79. Siddiqui AA, Fayiga Y, Huerta S. The role of endoscopic ultrasound in the evaluation of rectal cancer. Int Semin Surg Oncol 2006;3:36.
80. Tamerisa R, Irisawa A, Bhutani MS. Endoscopic ultrasound in the diagnosis, staging, and management of gastrointestinal and adjacent malignancies. Med Clin N Am 2005;89:139-58.
81. Ahmad NA, Kochman ML, Ginsberg GG. Endoscopic ultrasound and endoscopic mucosal resection for rectal cancers and villous adenomas. Hematol Oncol Clin N Am 2002;16:897-906.
82. Rotondano G, Esposito P, Pellecchia L, Novi A, Romano G. Early detection of locally recurrent rectal cancer by endosonography. Br J Radiol 1997;70:567-71.
83. Matsumoto T, Hizawa K, Esaki M, Kurahara K, Mizuno M, Hirakawa K et al. Comparison of EUS and magnifying colonoscopy for assessment of small colorectal cancers. Gastrointest Endosc 2002;56:354-60.
84. Tseng LJ, Jao YT, Mo LR. Preoperative staging of colorectal cancer with a balloon-sheathed miniprobe. Endoscopy 2002;34:564-8.
85. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med 1999;340:169-76.
86. Clevers H. Colon cancer: understanding how NSAIDs work. N Engl J Med 2006;354:761-3.
87. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-6.
88. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995;333:609-14.
89. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003;348:883-90.
90. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003;348:891-9.
91. Wadell WR, Ganser GF, Cerise EJ, Loughry RW. Sulindac for prophylaxis of the colon. Am J Surg 1989;157:175-9.
92. Jacoby RF, Cole CE, Tutsch K, Newton MA, Kelloff G, Hawk ET et al. Chemopreventive efficiency of combined piroxicam and difluoromethylornithine treatment of APC mutant Min mouse adenomas and selective toxicity against APC mutant embryos. Cancer Res 2000;60:1864-70.
93. Steinbach G, Lynch PM, Phillips RKS, Wallace MH, Hawk E, Gordon GB et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
94. Deenadayalu VP, Rex DK. Colon polyp retrieval after cold snaring. Gastrointest Endosc 2005;62:253-6.
95. Williams CB, Saunders BP, Talbot IC. Endoscopic management of polypoid early colon cancer. World J Surg 2000;24:1047-51.
96. Waye JD, Kahn O, Auerbach ME. Complications of colonoscopy and flexible sigmoidoscopy. Gastrointest Endosc Clin N Am 1996;6:343-77.
97. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS et al. Prevention of colorectal cancer by colonoscopic polypectomy: The National Polyp Study Workgroup. N Engl J Med 1993;329: 1977-81.
98. Soetikno RM, Gotoda T, Nakanishi Y, Soehendra N. Endoscopic mucosal resection. Gastrointest Endosc 2003;57:567-79.
99. Muto T, Oya M. Recent advances in diagnosis and treatment of colorectal T1 carcinoma. Dis Colon Rectum 2003;46 Suppl :S89-S93.
100. Cress RD, Morris CR, Wolfe BM. Cancer of the colon and rectum in California: trends in incidence by race/ethnicity, stage, and subsite. Prev Med 2000;31:447-53.
101. Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000;119:1219-27.
102. Atkin W, Martin JP. Stool DNA-based colorectal cancer detection: finding the needle in the haystack. J Natl Cancer Inst 2001;93:798-9.
103. Agrawal J, Syngal S. Colon cancer screening strategies. Curr Opin Gastroenterol 2005;21:59-63.
104. Lauschke H, Caspari R, Friedl W, Schwarz B, Mathiak M, Propping P et al. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer. Cancer Detect Prev 2001;25:55-61.
105. Lefkovitz Z, Shapiro R, Koch S, Cappell MS. The emerging role of virtual colonoscopy. Med Clin N Am 2005;89:111-38.
106. Zalis ME, Hahn PF. Digital subtraction bowel cleansing in CT colonography. AJR Am J Roentgenol 2001;176: 646-8.
107. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003;349:2191-200.
108. Hara AK, Johnson CD, MacCarty RL, Welch TJ. Incidental extracolonic findings on CT colonography. Radiology 2000;215:353-7.
109. Rex DK, Lieberman D. ACG colorectal cancer prevention action plan: update on CT-colonography. Am J Gastroenterol 2006;101:1410-3.
110. Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004;291:1713-9.
111. Royster AP, Fenlon HM, Clarke PD, Nunes DP, Ferrucci JT. CT colonoscopy of colorectal neoplasms: two-dimensional and three-dimensional virtual-reality techniques with colonoscopic correlation. AJR Am J Roentgenol 1997;169:1237-42.
112. Appleyard M, Glukhovsky A, Swain P. Wireless-capsule diagnostic endoscopy for recurrent small-bowel bleeding. N Engl J Med 2001;344:232-3.
113. Cotton PB, Barkun A, Ginsberg G, Hawes RH, Atkin W, Bjorkman DJ, et al. Diagnostic endoscopy: 2020 vision. Gastrointest Endosc 2006; 64:395-8.